Product Description: Lesofavumab (MHAB5553A) is a human IgG1κ anti-influenza B virus antibody[1].
Applications: COVID-19-anti-virus
Formula: N/A
References: [1]Rao GK, et al. In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection. Toxicol Sci. 2019 Jun 1;169(2):409-421./[2]Chai N, et al. A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action. Nat Commun. 2017 Jan 19;8:14234.